Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by earnings, at NOK 260B, ahead of Eli Lilly (NOK 200.2B) and Merck & Co (NOK 177.1B). Figures as of 18 Nov 2026, 20:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonNOK 260B
- Median
- NOK 572.4M
- Combined market value
- NOK 49.13T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | NOK 260B | NOK 6.38T | NOK 2,650.37 | 1.96% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | NOK 200.2B | NOK 11.97T | NOK 13,438.03 | 2.13% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | NOK 177.1B | NOK 3.3T | NOK 1,337.36 | 3.84% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | NOK 147.5B | NOK 1.69T | NOK 382.43 | 3.13% down | 17% down | ||
| 5 | NovartisNVS · Health Care | NOK 135.6B | NOK 2.84T | NOK 1,503.81 | 2.58% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | NOK 99.2B | NOK 2.69T | NOK 1,735.06 | 1.87% down | 2% up | ||
| 7 | SanofiSNY · Health Care | NOK 84.1B | NOK 1.1T | NOK 457.36 | 0.80% down | 4% down | ||
| 8 | PfizerPFE · Health Care | NOK 75.4B | NOK 1.55T | NOK 272.53 | 1.32% down | 14% up | ||
| 9 | GSKGSK · Health Care | NOK 73.6B | NOK 946.7B | NOK 472.30 | 1.12% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | NOK 68.4B | NOK 1.19T | NOK 580.07 | 2.53% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | NOK 63.3B | NOK 1.76T | NOK 1,016.85 | 0.11% up | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | NOK 43.7B | NOK 951.4B | NOK 9,196.98 | 1.01% down | 36% up | ||
| 13 | AbbVieABBV · Health Care | NOK 41B | NOK 4.9T | NOK 2,770.16 | 2.47% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | NOK 38.3B | NOK 1.32T | NOK 5,213.63 | 0.61% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | NOK 25.9B | NOK 340B | NOK 836.83 | 3.34% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 13.7B | NOK 477B | NOK 408.76 | 1.13% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | NOK 12.9B | NOK 239B | NOK 5,612.40 | 0.94% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | NOK 9.3B | NOK 305.9B | NOK 496.06 | 1.58% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | NOK 7.5B | NOK 385.5B | NOK 670.38 | 0.63% up | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | NOK 6.6B | NOK 48.7B | NOK 583.27 | 0.38% down | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 4.4B | NOK 121.3B | NOK 145.55 | 1.45% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | NOK 4.3B | NOK 96.3B | NOK 637.44 | 4.79% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | NOK 4.3B | NOK 55.7B | NOK 81.87 | 2.20% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | NOK 3.4B | NOK 115.3B | NOK 595.44 | 4.91% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | NOK 3B | NOK 194.4B | NOK 1,451.62 | 4.38% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | NOK 2.8B | NOK 447.5B | NOK 3,917.59 | 2.27% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | NOK 2.3B | NOK 75.8B | NOK 450.86 | 2.27% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | NOK 1.2B | NOK 58B | NOK 2,897.33 | 1.66% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | NOK 966.6M | NOK 72.4B | NOK 661.16 | 2.73% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | NOK 699M | NOK 73.6B | NOK 211.12 | 3.05% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 572.4M | NOK 72.4B | NOK 920.83 | 0.19% down | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -NOK 15.8M | NOK 59.5B | NOK 420.99 | 0.95% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -NOK 226.6M | NOK 58.5B | NOK 896.15 | 0.47% up | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -NOK 247.8M | NOK 47B | NOK 489.86 | 1.17% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -NOK 679M | NOK 51.2B | NOK 1,212.37 | 0.52% down | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -NOK 752.8M | NOK 61.5B | NOK 1,515.06 | 0.97% down | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -NOK 1B | NOK 63B | NOK 928.69 | 0.60% down | 241% up | ||
| 38 | ErascaERAS · Health Care | -NOK 1.2B | NOK 46.3B | NOK 131.82 | 2.16% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -NOK 1.3B | NOK 80B | NOK 1,225.61 | 1.35% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -NOK 1.5B | NOK 92.9B | NOK 977.87 | 7.46% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -NOK 1.6B | NOK 46.5B | NOK 825.48 | 2.16% down | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -NOK 1.6B | NOK 44B | NOK 402.17 | 1.38% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -NOK 1.8B | NOK 68.4B | NOK 1,300.35 | 1.39% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -NOK 1.8B | NOK 38.2B | NOK 278.98 | 2.11% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -NOK 1.9B | NOK 79.9B | NOK 1,151.99 | 1.84% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -NOK 2.3B | NOK 130.3B | NOK 260.64 | 3.95% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -NOK 2.5B | NOK 172.3B | NOK 2,627.04 | 0.13% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -NOK 2.8B | NOK 90.4B | NOK 3,889.51 | 4.98% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -NOK 2.9B | NOK 30.5B | NOK 157.34 | 0.68% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -NOK 2.9B | NOK 271.4B | NOK 374.52 | 0.26% down | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -NOK 2.9B | NOK 82.6B | NOK 2,954.76 | 0.15% down | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -NOK 3.2B | NOK 47.2B | NOK 271.12 | 0.36% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -NOK 3.5B | NOK 153.5B | NOK 2,390.69 | 2.39% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -NOK 3.6B | NOK 71B | NOK 810.69 | 1.80% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -NOK 3.7B | NOK 44.9B | NOK 269.37 | 3.00% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -NOK 7.1B | NOK 147.2B | NOK 755.64 | 1.43% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -NOK 7.6B | NOK 69.4B | NOK 497.91 | 0.62% down | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -NOK 9.3B | NOK 659.6B | NOK 206.47 | 1.64% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -NOK 10.5B | NOK 81.9B | NOK 102.38 | 1.08% down | 36% down | ||
| 60 | InsmedINSM · Health Care | -NOK 12.4B | NOK 255.3B | NOK 1,163.92 | 1.53% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -NOK 34.1B | NOK 228.9B | NOK 199.63 | 0.64% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7001 NOK).
Questions and answers
Which pharmaceutical companies rank first by earnings?
Johnson & Johnson (NOK 260B), Eli Lilly (NOK 200.2B) and Merck & Co (NOK 177.1B) are the top three of the 61 pharmaceutical companies ranked by earnings as of 18 Nov 2026, 20:14 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of NOK 49.13T as of 18 Nov 2026, 20:14 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.